Among all patients with positive EGFR-TK (n=24), an overwhelming majority (91.6%, n=22) had adenocarcinoma, while 8.3% (n=2) had adenosquamous carcinoma. This evidence concerns the gene EGFR and adenosquamous carcinoma.